January 21, 2021
Guided internet-based cognitive behavioral therapy (iCBT) outperformed both unguided iCBT and treatment as usual for treating depression, according to a new meta-analysis of 39 studies published in JAMA yesterday.
Additionally, researchers found that unguided iCBT also reduced depression symptom compared to treatment as usual and waiting list.
The difference between guided and unguided iCBT comes...
December 16, 2020
A recent mathematical simulation model found that, compared to other insomnia interventions like group cognitive behavioral therapy or pharmacotherapy, digital CBT delivered via Big Health's Sleepio was more cost-effective due to lower expenditures.
The research was funded by Big Health, and conducted by researchers from Johns Hopkins, the University of California, San Francisco, and the digital...
December 14, 2020
Bold Health, a London-based company developing digital therapeutics for gastrointestinal conditions, is backing a new University of Pennsylvania-led study that will directly compare the company's cognitive behavior therapy (CBT) app for irritable bowel syndrome (IBS) to Headspace's consumer mindfulness and meditation app.
According to a clinicaltrials.gov listing spotted by Exits & Outcomes,...
December 8, 2020
Editor's note: This story has been updated with quotes and additional information from Mahana's CEO and cofounder.
The FDA has granted a De Novo clearance to San Francisco-based Mahana Therapeutics' Parallel, a prescription digital therapeutic for patients with irritable bowel syndrome (IBS) that delivers cognitive behavioral therapy (CBT).
The agency made its decision on November 25, according...
September 29, 2020
New data suggest that an Internet-delivered cognitive behavioral therapy (ICBT) intervention not only remained effective after 12 months among adolescents with obsessive-compulsive disorder, but seemed to have an even greater impact on their symptoms with time.
Published last week in npj digital medicine, the analysis updated a previously reported three-month study with one-year data from the...
September 22, 2020
Cardiff-based female health pioneers have announced the launch of the UK’s first fully-integrated supplement range and a digital training programme to help manage the symptoms of menopause. The 'Health & Her Perimenopause and Menopause Food Supplements' are the result of research into over 50,000 women’s experiences and have been designed in collaboration with nutritional therapists to ensure...
July 29, 2020
A new randomized control trial published by the Anxiety and Depression Association of America found that participants using Big Health’s cognitive behavioral therapy app Daylight reduced symptoms of anxiety.
Researchers also found that participants using the app had a decrease in secondary symptoms such as worry and depressive symptoms.
“In this study, we found that Daylight helped participants...
June 18, 2020
Big Health, maker of digital health apps targeting poor sleep, worry and anxiety, has announced a $39 million Series B raise.
Gilde Health and Morningside Ventures headlined the funding. Samsung NEXT also participated in the raise, as did prior backers Kaiser Permanente Ventures and Octopus Ventures.
WHAT THEY DO
Big Health's two major digital health products Sleepio and Daylight are digital...
Above photo: A screengrab of the Wysa app,
May 20, 2020
Health insurer Aetna International announced that it is partnering with Wysa, an AI-powered chatbot and mental well-being app as part of the former’s ongoing efforts to address the 'second curve' of the COVID-19 pandemic – a less visible but increasing mental well-being crisis.
The health insurance company recently enhanced member access to a range of resources, including its virtual health...
April 29, 2020
Singapore-based digital health company, Intellect, which was founded in 2019, has recently launched an app that provides a new form of digital therapy without any human intervention. The personalized app transforms conventional face-to-face therapy into bite-sized modern self-therapy sessions at the user’s own convenience.
It tackles a variety of issues pertaining to the user’s personal...